Corbus Pharmaceuticals Holdings (CRBP) Cash from Investing Activities (2014 - 2025)

Corbus Pharmaceuticals Holdings' Cash from Investing Activities history runs 12 years deep, the most recent figure standing at $19.6 million for Q3 2025.

• On a quarterly basis, Cash from Investing Activities rose 227.81% year-over-year to $19.6 million in Q3 2025; TTM through Sep 2025 was $64.2 million, a 153.68% increase from a year earlier, with the FY2024 full-year figure at -$121.3 million, down 440.36% from the prior year.
• Cash from Investing Activities advanced to $19.6 million in Q3 2025 per CRBP's latest filing, from $17.7 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $43.0 million in Q1 2022 and bottomed at -$98.2 million in Q1 2024.
• The 5-year median for Cash from Investing Activities is $5.5 million (2023), against an average of -$3.9 million.
• Biggest YoY gain for Cash from Investing Activities was 600.2% in 2021; the steepest drop was 80886.76% in 2021.
• Year by year, Cash from Investing Activities stood at -$3.2 million in 2021, then soared by 470.74% to $11.8 million in 2022, then declined by 11.81% to $10.4 million in 2023, then declined by 15.96% to $8.7 million in 2024, then surged by 124.95% to $19.6 million in 2025.
• Per Business Quant, the three latest CRBP Cash from Investing Activities figures stand at $19.6 million (Q3 2025), $17.7 million (Q2 2025), and $18.1 million (Q1 2025).